MM&M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks about how the biotech company has evolved on the D&I front.
Salvatore Paolozza, senior director, sales ops, Antares Pharma, speaks about ways he’s leveraged technology to ensure Antares’ reps maintain contact with doctors.
John Kenyon, head of Meredith’s Targeted Media Health unit, discusses the launch of People en Español Salud and the company’s huge investment in the point-of-care space.
Ethan Lindenberger talks about how COVID-19 has led to a surge in vaccine misinformation online, social media’s efforts to quell its spread and more.
Sebby Borriello, VP and chief commercial officer of SK Life Science, details his company’s experience launching Xcopri, an epilepsy drug, during the COVID-19 crisis.
PatientPoint’s Linda Ruschau shares her thoughts on the recent evolution of the point-of-care space.
Pascale Communications’ Amy Houck and Vivvi Britton join MM&M’s Larry Dobrow to discuss LinkedIn’s evolution as an A-list vehicle for health marketers.
Phreesia’s David Linetsky reveals how the point-of-care space adapted its offerings for the coronavirus era in this week’s episode of The MM&M Podcast.
WebMD’s Dr. John Whyte returns to The MM&M Podcast to discuss his company’s ongoing coverage of the COVID-19 pandemic.
TBWA\WorldHealth’s #BlackHealthNow team speaks with Marc Iskowitz about why they started a conversation about black health, the philosophy behind their unique programming, and what it’s like to be driving this important effort amid the COVID-19 pandemic and as our nation grapples with racism.